免疫缺陷/调节失调相关的EBV阳性经典霍奇金淋巴瘤
Mohamed Nazem Alibrahim1, Annunziata Gloghini2, Antonino Carbone3
1Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
Cancers
|May 14, 2025
概括
典型的霍奇金淋巴瘤 (cHL) 是由爱斯坦-巴尔病毒 (EBV) 驱动的,在免疫功能低下的患者中,需要新的分类和治疗方法. 了解 EBV 的理解
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫缺陷/失调在古典霍奇金淋巴瘤 (cHL) 中是一个严重的未满足的需求.
- 爱斯坦-巴尔病毒 (EBV) 是高风险cHL的关键驱动因素,操纵免疫反应和瘤微环境.
- 免疫抑制群体中的EBV阳性cHL与EBV阴性cHL相比具有明显的分子特征.
研究的目的:
- 在免疫失调的环境中审查EBV在cHL病原体中的病因作用.
- 探索与EBV相关的cHL的免疫背景和分子特征的差异.
- 突出需要修订分类和针对病毒和免疫复杂性的治疗策略.
主要方法:
- 文献综述综合了关于EBV在cHL中的作用的当前知识.
- 对EBV阳性cHL的独特分子标志和免疫逃避机制的分析.
- 讨论治疗挑战和未来方向,包括世卫组织分类的影响.
主要成果:
- 埃博病毒coproteins利用免疫弱点,激活NF-κB,并通过PD-L1.1促进免疫抑制.
- 具有EBV阳性的cHL显示了减少的体质突变和独特的HLA关联.
- 艾滋病毒的同时感染会加剧cHL的发病,导致M2巨细胞的主导地位和T细胞枯竭.
结论:
- 与EBV相关的cHL值得重新归类为一个独特的子集,整合病毒状态和免疫生物标志物.
- 目前的治疗方法不足以解决这一高风险群体中病毒和免疫复杂性的问题.
- 紧急优先事项包括流行病学研究,开发针对病毒的治疗方法和个性化治疗方案.
相关概念视频
Immunodeficiency Diseases
874
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
874
B Cell Activation and Differentiation
1.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.3K


